LIN LINDE PLC
Industrial Inorganic Chemicals · Nasdaq · SEC CIK 1707925 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY8.2%
TTM net income YoY-1.2%
TTM EPS YoY0.8%
Revenue 3-yr CAGR3.7%
Net income 3-yr CAGR5.4%
Margins
Gross margin47.9%
Operating margin25.3%
Net margin19.3%
FCF margin14.0%
EBITDA margin35.8%
Returns
ROE18.0%
ROA8.1%
ROIC (approx.)12.5%
Asset turnover0.42x
Leverage & solvency
Liabilities / assets53.5%
Debt / equity0.56x
Current ratio0.86x
Interest coverage35.51x
Cash quality & payout
Operating cash flow / net income1.53x
Accruals ratio-4.3%
Payout ratio41.6%
Capex / revenue15.5%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $33.99B | $33.01B | $32.85B | $33.36B | $30.79B |
| Cost of revenue | $17.39B | $17.14B | $17.49B | $19.45B | $17.54B |
| Gross profit | $16.60B | $15.86B | $15.36B | $13.91B | $13.25B |
| R&D expense | $147.00M | $150.00M | $146.00M | $143.00M | $143.00M |
| SG&A expense | $3.43B | $3.34B | $3.29B | $3.11B | $3.19B |
| Operating income | $8.92B | $8.63B | $8.02B | $5.37B | $4.98B |
| Interest expense | $255.00M | $256.00M | $200.00M | $63.00M | $227.00M |
| Pretax income | $8.90B | $8.57B | $7.99B | $5.54B | $5.10B |
| Income tax | $1.99B | $2.00B | $1.81B | $1.43B | $1.26B |
| Net income | $6.90B | $6.57B | $6.20B | $4.15B | $3.83B |
| EBITDA | $12.69B | $12.41B | $11.84B | $9.57B | $9.62B |
| EPS (basic) | 14.69 | 13.71 | 12.70 | 8.30 | 7.40 |
| EPS (diluted) | 14.61 | 13.62 | 12.59 | 8.23 | 7.33 |
| Dividends declared per share | 6.00 | 5.56 | 5.10 | 4.68 | 4.24 |
| Weighted avg. shares (diluted) | 472.19M | 482.09M | 492.29M | 504.04M | 521.88M |
| Banking | |||||
| Net interest income | -$255.00M | -$256.00M | -$200.00M | -$63.00M | -$77.00M |
| Balance sheet | |||||
| Cash & equivalents | $5.06B | $4.85B | $4.66B | $5.44B | $2.82B |
| Receivables | $4.97B | $4.62B | $4.72B | $4.56B | $4.50B |
| Inventory | $2.06B | $1.95B | $2.12B | $1.98B | $1.73B |
| Current assets | $13.32B | $12.95B | $12.62B | $13.05B | $10.16B |
| PP&E, net | $28.26B | $24.77B | $24.55B | $23.55B | $26.00B |
| Goodwill | $27.93B | $25.94B | $26.75B | $25.82B | $27.04B |
| Intangibles | $11.87B | $11.33B | $12.40B | $12.42B | $13.80B |
| Total assets | $86.82B | $80.15B | $80.81B | $79.66B | $81.61B |
| Current liabilities | $15.20B | $14.54B | $15.72B | $16.48B | $13.64B |
| Short-term debt | $1.80B | $2.06B | $1.26B | $1.60B | $1.71B |
| Long-term debt | $20.68B | $15.34B | $13.40B | $12.20B | $11.34B |
| Total debt | $22.48B | $17.40B | $14.66B | $13.80B | $13.04B |
| Total liabilities | $47.08B | $40.66B | $39.72B | $38.27B | $36.16B |
| Shareholders' equity | $38.24B | $38.09B | $39.72B | $40.03B | $44.03B |
| Net debt | $17.42B | $12.55B | $10.00B | $8.36B | $10.22B |
| Shares outstanding | — | — | — | — | 508.68M |
| Cash flow statement | |||||
| Operating cash flow | $10.35B | $9.42B | $9.30B | $8.86B | $9.72B |
| Capital expenditure | $5.26B | $4.50B | $3.79B | $3.17B | $3.09B |
| Free cash flow | $5.09B | $4.93B | $5.52B | $5.69B | $6.64B |
| Investing cash flow | -$5.72B | -$4.64B | -$4.67B | -$3.09B | -$3.01B |
| Financing cash flow | -$4.55B | -$4.36B | -$5.40B | -$3.09B | -$7.59B |
| Depreciation & amortization | $3.76B | $3.78B | $3.82B | $4.20B | $4.63B |
| Stock-based compensation | $164.00M | $160.00M | $141.00M | $107.00M | $128.00M |
| Dividends paid | $2.81B | $2.65B | $2.48B | $2.34B | $2.19B |
| Share buybacks | $4.60B | $4.48B | $3.96B | $5.17B | $4.61B |
Free plan shows the latest 5 periods; Pro shows all 10 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.